Drug Discovery · South San Francisco, CA · Founded 2018 · Privately Held (backing)
Operator of a biotechnology company intended for the treatment of immunological diseases and cancer. Electra Therapeutics is based in South San Francisco, CA and was founded in 2018. It was valued at $479 million at its later-stage round in Oct 2025, the last priced event on record. It has raised $301 million across 2 recorded rounds; the latest was an $183 million Series C in Oct 2025.
PMV mark · valuation
$479.0M
Oct 2026
Priced at
its later-stage round
Oct 2025
Total raised
$301.0M
Last round
Later Stage VC (Series C)
Oct 2025
Cap table — not yet on record
Electra Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Electra Therapeutics with a free account
·The complete investor list: 14 names
·Watch Electra Therapeutics: the Monday email on marks, rounds and moves
Where does Electra Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Electra Therapeutics's 2 recorded funding rounds.
